For many Life Sciences Executives, cybersecurity often appears as a necessary, yet burdensome, cost—a drain on resources with an elusive return. The challenge lies in demonstrating its tangible value beyond mere compliance. However, a closer look reveals a stark reality: the true cost of cyber insecurity far outweighs proactive investment. A compromised network or stolen intellectual property can threaten everything from your firm’s financial stability and research integrity to investor confidence and clinical trial timelines, impacting your valuation and competitive position.